BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20333741)

  • 1. In vitro investigation of wavelength-dependent tissue ablation: laser prostatectomy between 532 nm and 2.01 microm.
    Kang HW; Kim J; Peng YS
    Lasers Surg Med; 2010 Mar; 42(3):237-44. PubMed ID: 20333741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 980-nm Diode laser: a novel laser technology for vaporization of the prostate.
    Wendt-Nordahl G; Huckele S; Honeck P; Alken P; Knoll T; Michel MS; Häcker A
    Eur Urol; 2007 Dec; 52(6):1723-8. PubMed ID: 17611013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angular effect of optical fiber movement on endoscopic laser prostatectomy.
    Rajabhandharaks D; Kang HW; Oh J
    Lasers Surg Med; 2012 Oct; 44(8):653-63. PubMed ID: 22899315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation.
    Bach T; Huck N; Wezel F; Häcker A; Gross AJ; Michel MS
    BJU Int; 2010 Aug; 106(3):368-72. PubMed ID: 19912204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardium tissue ablation with high-peak-power nanosecond 1,064- and 532-nm pulsed lasers: influence of laser-induced plasma.
    Ogura M; Sato S; Ishihara M; Kawauchi S; Arai T; Matsui T; Kurita A; Kikuchi M; Ashida H; Obara M
    Lasers Surg Med; 2002; 31(2):136-41. PubMed ID: 12210598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations.
    Seitz M; Bayer T; Ruszat R; Tilki D; Bachmann A; Gratzke C; Schlenker B; Stief C; Sroka R; Reich O
    BJU Int; 2009 Mar; 103(6):770-5. PubMed ID: 18990158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoactive dye-enhanced tissue ablation for endoscopic laser prostatectomy.
    Ahn M; Hau NT; Van Phuc N; Oh J; Kang HW
    Lasers Surg Med; 2014 Nov; 46(9):703-11. PubMed ID: 25164484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mid-IR laser ablation of articular and fibro-cartilage: a wavelength dependence study of thermal injury and crater morphology.
    Youn JI; Sweet P; Peavy GM; Venugopalan V
    Lasers Surg Med; 2006 Mar; 38(3):218-28. PubMed ID: 16453331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thermal tissue effects induced by contact application of fiber guided laser systems.
    Janda P; Sroka R; Mundweil B; Betz CS; Baumgartner R; Leunig A
    Lasers Surg Med; 2003; 33(2):93-101. PubMed ID: 12913880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laser treatment of benign prostatic hyperplasia].
    Muschter R; Hofstetter A
    Urologe A; 1994 Jul; 33(4):281-7. PubMed ID: 7524230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia.
    Narayan P; Tewari A; Aboseif S; Evans C
    J Urol; 1995 Dec; 154(6):2083-8. PubMed ID: 7500464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G; Madersbacher S; Lang T; Marberger M
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of mass removal, thermal injury, and crater morphology of cortical bone ablation using wavelengths 2.79, 2.9, 6.1, and 6.45 microm.
    Youn JI; Sweet P; Peavy GM
    Lasers Surg Med; 2007 Apr; 39(4):332-40. PubMed ID: 17457836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Holmium: YAG laser prostatectomy canine feasibility study.
    Kabalin JN
    Lasers Surg Med; 1996; 18(3):221-4. PubMed ID: 8778515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual laser ablation of the canine prostate with a diffusing fiber and an 805-nanometer diode laser.
    Cromeens DM; Johnson DE; Stephens LC; Gray KN
    Lasers Surg Med; 1996; 19(2):135-42. PubMed ID: 8887915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quartz head contact laser fiber: a novel fiber for laser ablation of the prostate using the 980 nm high power diode laser.
    Shaker HS; Shoeb MS; Yassin MM; Shaker SH
    J Urol; 2012 Feb; 187(2):575-9. PubMed ID: 22177175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laser therapy for benign prostate hyperplasia].
    Muschter R
    Aktuelle Urol; 2008 Sep; 39(5):359-68. PubMed ID: 18798125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro study of the soft tissue effects of microsecond-pulsed CO(2) laser parameters during soft tissue incision and sulcular debridement.
    Vaderhobli RM; White JM; Le C; Ho S; Jordan R
    Lasers Surg Med; 2010 Mar; 42(3):257-63. PubMed ID: 20333737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid infrared optical parametric oscillator (OPO) as a viable alternative to tissue ablation with the free electron laser (FEL).
    Mackanos MA; Simanovskii D; Joos KM; Schwettman HA; Jansen ED
    Lasers Surg Med; 2007 Mar; 39(3):230-6. PubMed ID: 17304561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of multiple-sweeping on ablation performance during ex vivo laser nephrectomy.
    Oh J; Nam SY; Lee YW; Kang HW
    Lasers Surg Med; 2016 Aug; 48(6):616-23. PubMed ID: 26990980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.